This statistic presents the sales revenue of over-the-counter (OTC), non refundable and not listed pharmacy type products in France, from January to July 2018, distributed by medication type. It reveals that muscle analgesics represented 71 million euros of the total sales revenue of pharmaceuticals between January and July 2018.
Sales revenue of over-the-counter (OTC) non refundable and not listed pharmacy type products in France from January to July 2018, by product type (in million euros)
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Statistics on
About the industry
10
- Premium Statistic Leading European pharmaceutical companies by Rx sales 2022
- Basic Statistic Net sales of Recipharm 2009-2022
- Premium Statistic Top global companies by orphan drug revenues 2023
- Premium Statistic Pharma market value in Colombia 2008-2021
- Premium Statistic Pharma market value in Argentina 2008-2021
- Basic Statistic EBITDA of Recipharm 2009-2021
- Basic Statistic Annual profit of Recipharm 2009-2020
- Premium Statistic Parapharmaceuticals sales in Russia 2019-2020, by product
- Basic Statistic Leading pharmaceutical & biotech companies in selected EU countries 2022
- Premium Statistic Top therapeutic classes by global pharmaceutical sales 2018 estimates
About the region
10
- Premium Statistic Revenue of the top ten pharmaceutical companies in France 2021
- Premium Statistic Total liabilities of the Ipsen group 2014-2019
- Basic Statistic Production value of pharmaceutical products & preparations in France 2012-2021
- Premium Statistic Research and development expenditure of the Ipsen group 2014-2019
- Premium Statistic Total equity of the Ipsen group 2014-2019
- Premium Statistic Share of generic drugs in the pharmaceutical market in France 2018
- Premium Statistic Number of companies in the pharmaceutical industry in France 1970-2018
- Premium Statistic Retail pharmacy market as a percentage of total revenues in France 2018, by therapy
- Premium Statistic Drug revenue in France 2010-2018
- Basic Statistic Main players in the distribution of medicines in France 2018
Selected statistics
9
- Premium Statistic Global pharmaceutical pipeline by therapy area 2013-2017
- Premium Statistic Merck & Co - expenditure on research and development 2006-2023
- Basic Statistic Merck & Co total assets 2009-2023
- Basic Statistic Merck & Co cash dividends declared 2006-2023
- Premium Statistic AstraZeneca's expenditure on research and development 2006-2023
- Premium Statistic Sales of Johnson & Johnson worldwide 2011-2023, by segment
- Premium Statistic Sales of Johnson & Johnson 2006-2023 by region
- Premium Statistic Johnson & Johnson's number of employees 2004-2023
- Premium Statistic U.S. branded prescription revenue forecast 2009-2015
Other regions
10
- Premium Statistic Foreign-to-Canadian generic drug price ratios by OECD country as of 2018
- Premium Statistic Average price of drugs sold in pharmacies in Spain 2022, by therapeutic group
- Premium Statistic Top 3 therapeutic areas by spending in the U.S. 2015-2020
- Premium Statistic Pharma e-commerce sales value growth in Russia 2020, by product
- Basic Statistic Quarterly medical cannabis oil products sold in Canada 2016-2019
- Premium Statistic Venezuela: pharma industry market value 2008-2017
- Premium Statistic Peru: pharmaceutical industry GDP 2007-2017
- Premium Statistic Mexico: pharma industry market value 2008-2016
- Basic Statistic Public expenditure on biotechnology research & development in Europe 2021
- Basic Statistic Alaska's medical cannabis spending 2018-2024
Related statistics
10
- Premium Statistic Chemical peel facial rejuvenation market size worldwide from 2016-2026
- Basic Statistic Hospital drug spending in Canada by province 2018
- Basic Statistic Share of drug spending in hospitals in Canada by province 2018
- Premium Statistic Botulinum toxin facial rejuvenation market size worldwide from 2016-2026
- Premium Statistic Soft tissue fillers facial rejuvenation market size worldwide from 2016-2026
- Basic Statistic Average cost of hospital per day by country 2015
- Basic Statistic Leading U.S. states by value of unpaid care given by dementia caregivers 2023
- Basic Statistic Alzheimer and other dementia caregivers' unpaid care in the U.S. 2011-2023
- Premium Statistic Reasons for hospitalizations of US Alzheimer sufferers 2010
- Basic Statistic Ages of Alzheimer/dementia caregivers in the U.S. in 2023
Further related statistics
9
- CVS Health's total assets 2005-2023
- Walgreens gross profit and net earnings in the U.S. 2005-2023
- Revenue of Sinopharm 2011-2022, by category
- Annual revenue of Shanghai Pharmaceuticals 2011-2022
- M&A capacities - changes for the global pharma industry 2008-2015
- Expenditure worldwide on diabetes by market 2013-2018
- Chinese insulin market distribution: leading companies 2011
- U.S. insulin market distribution: leading companies 2011
- Alzheimer's amongst older people in 2050: impact of a 5-year delay in onset
Further Content: You might find this interesting as well
Statistics
- CVS Health's total assets 2005-2023
- Walgreens gross profit and net earnings in the U.S. 2005-2023
- Revenue of Sinopharm 2011-2022, by category
- Annual revenue of Shanghai Pharmaceuticals 2011-2022
- M&A capacities - changes for the global pharma industry 2008-2015
- Expenditure worldwide on diabetes by market 2013-2018
- Chinese insulin market distribution: leading companies 2011
- U.S. insulin market distribution: leading companies 2011
- Alzheimer's amongst older people in 2050: impact of a 5-year delay in onset
IQVIA. (August 1, 2018). Sales revenue of over-the-counter (OTC) non refundable and not listed pharmacy type products in France from January to July 2018, by product type (in million euros) [Graph]. In Statista. Retrieved May 13, 2024, from https://www.statista.com/statistics/957975/sales-revenue-otc-pharmaceuticals-france/
IQVIA. "Sales revenue of over-the-counter (OTC) non refundable and not listed pharmacy type products in France from January to July 2018, by product type (in million euros)." Chart. August 1, 2018. Statista. Accessed May 13, 2024. https://www.statista.com/statistics/957975/sales-revenue-otc-pharmaceuticals-france/
IQVIA. (2018). Sales revenue of over-the-counter (OTC) non refundable and not listed pharmacy type products in France from January to July 2018, by product type (in million euros). Statista. Statista Inc.. Accessed: May 13, 2024. https://www.statista.com/statistics/957975/sales-revenue-otc-pharmaceuticals-france/
IQVIA. "Sales Revenue of Over-the-counter (Otc) Non Refundable and Not Listed Pharmacy Type Products in France from January to July 2018, by Product Type (in Million Euros)." Statista, Statista Inc., 1 Aug 2018, https://www.statista.com/statistics/957975/sales-revenue-otc-pharmaceuticals-france/
IQVIA, Sales revenue of over-the-counter (OTC) non refundable and not listed pharmacy type products in France from January to July 2018, by product type (in million euros) Statista, https://www.statista.com/statistics/957975/sales-revenue-otc-pharmaceuticals-france/ (last visited May 13, 2024)
Sales revenue of over-the-counter (OTC) non refundable and not listed pharmacy type products in France from January to July 2018, by product type (in million euros) [Graph], IQVIA, August 1, 2018. [Online]. Available: https://www.statista.com/statistics/957975/sales-revenue-otc-pharmaceuticals-france/